Maria Palasis
Chief Executive Officer at LYRA THERAPEUTICS, INC.
Net worth: - $ as of 30/03/2024
Profile
Dr. Maria Palasis is a President, Chief Executive Officer & Director at Lyra Therapeutics, Inc. She is on the Board of Directors at Beta Bionics, Inc., Lyra Therapeutics, Inc., Medexecwomen and PanTher Therapeutics, Inc. Dr. Palasis was previously employed as a President, Chief Executive Officer & Director by Arsenal Medical, Inc. She also served on the board at Boston Scientific Corp.
She received her undergraduate degree from the University of Cincinnati (Ohio) and a doctorate degree from the University of Cincinnati (Ohio).
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
LYRA THERAPEUTICS, INC.
-.--% | 17/03/2024 | 0 ( -.--% ) | - $ | 30/03/2024 |
Maria Palasis active positions
| Companies | Position | Start |
|---|---|---|
| LYRA THERAPEUTICS, INC. | Chief Executive Officer | 31/12/2014 |
PanTher Therapeutics, Inc.
 PanTher Therapeutics, Inc. Medical/Nursing ServicesHealth Services PanTher Therapeutics, Inc. provides health care services for the treatment of inoperable locally advanced solid tumors. The firm designed its delivery method to eliminate the toxicity and debilitating side effects that chemo agents can produce when delivered systemically through traditional IV or oral administration. The company was founded by Laura Indolfi, Elazer R. Edelman and David T. Ting in May 2014 is headquartered in Cambridge, MA. | Director/Board Member | - |
| Medexecwomen | Director/Board Member | - |
Beta Bionics, Inc.
 Beta Bionics, Inc. Medical SpecialtiesHealth Technology Beta Bionics, Inc. operates a medical technology company leveraging lifelong, machine-learning, artificial intelligence to develop and commercialize the autonomous bionic pancreas. The company was founded by Edward R. Damiano in October 21, 2015 and is headquartered in Boston, MA. | Director/Board Member | 31/12/2021 |
Former positions of Maria Palasis
| Companies | Position | End |
|---|---|---|
Arsenal Medical, Inc.
 Arsenal Medical, Inc. Miscellaneous Commercial ServicesCommercial Services Arsenal Medical Inc. develops therapeutic products based on BioActive Composites platform. Its biomaterials-based systems provide targeted local and systemic therapies to treat chronic diseases and conditions. The firm product offers tailored dosing of drugs, mechanical and biochemical compatibility with tissues and complete bioabsorption. The company was founded by George M. Whitesides, Carmichael S. Roberts Jr. and Robert S. Langer Jr. in 2005 and is headquartered in Watertown, MA. | Chief Executive Officer | 31/05/2018 |
| BOSTON SCIENTIFIC CORPORATION | Director/Board Member | 31/12/2007 |
Training of Maria Palasis
| University of Cincinnati (Ohio) | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 2 |
|---|---|
| BOSTON SCIENTIFIC CORPORATION | Distribution Services |
| LYRA THERAPEUTICS, INC. | Health Technology |
| Private companies | 4 |
|---|---|
Arsenal Medical, Inc.
Arsenal Medical, Inc. Miscellaneous Commercial ServicesCommercial Services Arsenal Medical Inc. develops therapeutic products based on BioActive Composites platform. Its biomaterials-based systems provide targeted local and systemic therapies to treat chronic diseases and conditions. The firm product offers tailored dosing of drugs, mechanical and biochemical compatibility with tissues and complete bioabsorption. The company was founded by George M. Whitesides, Carmichael S. Roberts Jr. and Robert S. Langer Jr. in 2005 and is headquartered in Watertown, MA. | Commercial Services |
PanTher Therapeutics, Inc.
PanTher Therapeutics, Inc. Medical/Nursing ServicesHealth Services PanTher Therapeutics, Inc. provides health care services for the treatment of inoperable locally advanced solid tumors. The firm designed its delivery method to eliminate the toxicity and debilitating side effects that chemo agents can produce when delivered systemically through traditional IV or oral administration. The company was founded by Laura Indolfi, Elazer R. Edelman and David T. Ting in May 2014 is headquartered in Cambridge, MA. | Health Services |
Beta Bionics, Inc.
Beta Bionics, Inc. Medical SpecialtiesHealth Technology Beta Bionics, Inc. operates a medical technology company leveraging lifelong, machine-learning, artificial intelligence to develop and commercialize the autonomous bionic pancreas. The company was founded by Edward R. Damiano in October 21, 2015 and is headquartered in Boston, MA. | Health Technology |
| Medexecwomen |
- Stock Market
- Insiders
- Maria Palasis
